COVAX-19

id: covax-19-250-823028
title: COVAX-19
text: COVAX-19 is a recombinant protein-based COVID-19 vaccine developed by South Australian-based biotech company Vaxine, in collaboration with CinnaGen, a private company with operations in the Middle East. It is under clinical trial in collaboration with the Iranian company CinnaGen.
brand slug: wiki
category slug: encyclopedia
description: Vaccine candidate against COVID-19
original url: https://en.wikipedia.org/wiki/COVAX-19
date created:
date modified: 2024-04-25T17:18:26Z
main entity: {"identifier":"Q107864269","url":"https://www.wikidata.org/entity/Q107864269"}
image: {"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Coronavirus._SARS-CoV-2.png","width":2048,"height":2048}
fields total: 13
integrity: 15

Related Entries

Explore Next Part